Kenneth Todd Moore

The Changing Application of Vulnerability Across the Different Phases of Clinical Research

ABSTRACT The United States Food and Drug Omnibus Reform Act (FDORA) of 2022 established a legislative mandate requiring sponsors of pharmaceutical research to actively enhance the inclusion of historically underrepresented populations in clinical trials. This policy reflects the...